| Cisplatin and DNA repair in cancer chemotherapy DB Zamble, SJ Lippard Trends in biochemical sciences 20 (10), 435-439, 1995 | 699 | 1995 |
| HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. JC Huang, DB Zamble, JT Reardon, SJ Lippard, A Sancar Proceedings of the National Academy of Sciences 91 (22), 10394-10398, 1994 | 500 | 1994 |
| Repair of cisplatin− DNA adducts by the mammalian excision nuclease DB Zamble, D Mu, JT Reardon, A Sancar, SJ Lippard Biochemistry 35 (31), 10004-10013, 1996 | 467 | 1996 |
| Nickel homeostasis and nickel regulation: an overview Y Li, DB Zamble Chemical reviews 109 (10), 4617-4643, 2009 | 247 | 2009 |
| p53-Dependent and-independent responses to cisplatin in mouse testicular teratocarcinoma cells DB Zamble, T Jacks, SJ Lippard Proceedings of the National Academy of Sciences 95 (11), 6163-6168, 1998 | 190 | 1998 |
| The polymerization behavior of [1]-and [2] ferrocenophanes containing silicon atoms in the bridge: comparison of the molecular structure of the strained, polymerizable cyclic … W Finckh, BZ Tang, DA Foucher, DB Zamble, R Ziembinski, A Lough, ... Organometallics 12 (3), 823-829, 1993 | 178 | 1993 |
| The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition JG Heddle, SJ Blance, DB Zamble, F Hollfelder, DA Miller, LM Wentzell, ... Journal of molecular biology 307 (5), 1223-1234, 2001 | 169 | 2001 |
| A role for SlyD in the Escherichia coli hydrogenase biosynthetic pathway JW Zhang, G Butland, JF Greenblatt, A Emili, DB Zamble Journal of Biological Chemistry 280 (6), 4360-4366, 2005 | 166 | 2005 |
| NikR–operator complex structure and the mechanism of repressor activation by metal ions ER Schreiter, SC Wang, DB Zamble, CL Drennan Proceedings of the National Academy of Sciences 103 (37), 13676-13681, 2006 | 155 | 2006 |
| [NiFe]-hydrogenase maturation MJ Lacasse, DB Zamble Biochemistry 55 (12), 1689-1701, 2016 | 126 | 2016 |
| Metallocenter assembly of the hydrogenase enzymes MR Leach, DB Zamble Current opinion in chemical biology 11 (2), 159-165, 2007 | 120 | 2007 |
| Testis-specific HMG-domain protein alters the responses of cells to cisplatin DB Zamble, Y Mikata, CH Eng, KE Sandman, SJ Lippard Journal of inorganic biochemistry 91 (3), 451-462, 2002 | 115 | 2002 |
| Microbial nickel proteins H Kaluarachchi, KCC Chung, DB Zamble Natural product reports 27 (5), 681-694, 2010 | 109 | 2010 |
| Selectivity of metal binding and metal-induced stability of Escherichia coli NikR SC Wang, AV Dias, SL Bloom, DB Zamble Biochemistry 43 (31), 10018-10028, 2004 | 109 | 2004 |
| The role of complex formation between the Escherichia coli hydrogenase accessory factors HypB and SlyD MR Leach, JW Zhang, DB Zamble Journal of biological chemistry 282 (22), 16177-16186, 2007 | 107 | 2007 |
| Metal binding activity of the Escherichia coli hydrogenase maturation factor HypB MR Leach, S Sandal, H Sun, DB Zamble Biochemistry 44 (36), 12229-12238, 2005 | 104 | 2005 |
| Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities EE Trimmer, DB Zamble, SJ Lippard, JM Essigmann Biochemistry 37 (1), 352-362, 1998 | 104 | 1998 |
| Escherichia coli HypA Is a Zinc Metalloprotein with a Weak Affinity for Nickel A Atanassova, DB Zamble Journal of Bacteriology 187 (14), 4689-4697, 2005 | 100 | 2005 |
| Metal-selective DNA-binding response of Escherichia coli NikR SL Bloom, DB Zamble Biochemistry 43 (31), 10029-10038, 2004 | 100 | 2004 |
| The response of cellular proteins to cisplatin‐damaged DNA DB Zamble, SJ Lippard Cisplatin: chemistry and biochemistry of a leading anticancer drug, 71-110, 1999 | 78 | 1999 |
